(NasdaqGM:REFI), CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) (“Chicago Atlantic” or the “Company”), a commercial mortgage real estate investment trust, today announced its results for the quarter ended June 30, 2025. Peter Sack, Co-Chief Executive Officer, noted, “As our second quarter results demonstrate, we are managing our […]
(NasdaqGM:RNAC), Initiated Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Preliminary data from Phase 2 trial of Descartes-08 in systemic lupus erythematosus expected in 2H25 Initiation of Phase 2 pediatric basket trial of Descartes-08 in select autoimmune indications expected in 2H25 Approximately $162.1 million cash, cash equivalents and restricted cash as of June 30,
(CNSX:YMC.CN),(CNSX:YMC),(Boerse Frankfurt – Freiverkehr:E770),(OTC US:YMMCF),(Other OTC:YMMCF), VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company“) is pleased to provide an update from its inaugural drill program at the 100%-owned 13,100-hectare AZ Project located approximately 6 kilometres west of the Alaska Highway
(NASDAQ:AKBA), Continued Vafseo(R) (vadadustat) growth with Q2 2025 net product revenues increasing to $13.3 million; Total Q2 2025 net product revenues increased to $60.5 million DaVita physicians are expected to begin treating patients with Vafseo in August 2025 as part of an operational pilot at 100+ DaVita dialysis clinics Patient enrollment completed in VOICE, a
(NASDAQ:LEE), Adjusted EBITDA(1) growth of 92% over Q2Total Digital Revenue(2) of $78M represented 55% of total revenueDigital-Only subscription revenue increased 16% YOY(3)Amplified Digital(R) Agency revenue totaled $29M, or up 10% YOY(3) DAVENPORT, Iowa, Aug. 07, 2025 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NASDAQ: LEE), a digital-first subscription platform providing high quality, trusted, local news, information
(NasdaqGM:RAPP), RAP-219 Phase 2a trial in patients with drug-resistant focal onset seizures is fully enrolled and on track for topline results in September 2025 Phase 2 trial of RAP-219 in bipolar mania has been initiated and is enrolling patients; trial remains on track, with topline results anticipated in the first half of 2027 Ended the
(NASDAQ:DDOG), Second quarter revenue grew 28% year-over-year to $827 million Robust growth of larger customers, with about 3,850 $100k+ ARR customers, up from about 3,390 a year ago Unveiled more than 125 products, capabilities and features at DASH 2025 NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Datadog, Inc. (NASDAQ:DDOG), the monitoring and security platform
(NASDAQ:GOGO), Total Revenue of $226.0 million, up 121% Year-over-Year; Service Revenue of $194.0 million, up 137% Year-over-Year Net Income of $12.8 million; Adjusted EBITDA(1) of $61.7 million, up 103% Year-over-Year 77 HDX shipments year to date Reiterates 4Q 2025 launch timing for 5G Increases 2025 Financial Guidance, which includes current impact of global tariffs BROOMFIELD,
(NASDAQ:ADV), Strong profitability growth in Experiential and Retailer Services Advancing transformation initiatives to accelerate AI enablement and improved business insights Expecting improved financial performance and cash generation in the second half of the year Reaffirming 2025 guidance ST. LOUIS, Aug. 07, 2025 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” “Advantage Solutions,” the “Company,”
(NasdaqGM:ULBI), NEWARK, N.Y., Aug. 07, 2025 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2025 with the following results: Sales of $48.6 million increased 13.0% from $43.0 million for the second quarter of 2024; excluding Electrochem, sales of $39.3 million declined 8.7% due to a 57.2%